SJS Investment Consulting’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164 Sell
31
-42
-58% -$269 ﹤0.01% 2516
2026
Q1
$532 Buy
73
+52
+248% +$471 ﹤0.01% 1715
2025
Q4
$203 Buy
+21
New +$217 ﹤0.01% 1808
2024
Q1
Sell
-10
Closed -$195 1675
2023
Q4
$195 Hold
10
﹤0.01% 1463
2023
Q3
$213 Buy
10
+3
+43% +$78 ﹤0.01% 1441
2023
Q2
$233 Sell
7
-6
-46% -$221 ﹤0.01% 1376
2023
Q1
$512 Buy
13
+2
+18% +$83 ﹤0.01% 1145
2022
Q4
$464 Buy
11
+3
+38% +$115 ﹤0.01% 1245
2022
Q3
$0 Buy
+8
New +$333 ﹤0.01% 1387
2022
Q1
$0 Buy
+2
New +$99 ﹤0.01% 1145

Other funds holding NUS

SJS Investment Consulting's NUS Position: Q2 2026 in Review

SJS Investment Consulting reduced its Nu Skin (NUS) stake by 58% in Q2 2026, selling an estimated $269 and leaving 31 shares worth $164. The position accounts for ﹤0.01% of the portfolio, ranked #2516.

SJS Investment Consulting first reported a position in NUS in Q1 2022 and has held it in 10 quarters since. The position peaked at $532 in Q1 2026. 161 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • SJS Investment Consulting held 31 shares of Nu Skin worth $164 as of Q2 2026.
  • SJS Investment Consulting sold 42 Nu Skin shares in Q2 2026, an estimated $269.
  • Nu Skin made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2516 holding.
  • SJS Investment Consulting first reported a position in Nu Skin in Q1 2022 and has held it in 10 quarters since.
  • SJS Investment Consulting's Nu Skin position peaked at $532 in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.